Jb Chemicals And Pharma Sustainability Profile
J.B. Chemicals and Pharmaceuticals Ltd., commonly referred to as J.B. Pharma, is a prominent player in the pharmaceutical industry, headquartered in Mumbai, India. Established in 1976, the company has made significant strides in the development and manufacturing of a diverse range of pharmaceutical products, including formulations and active pharmaceutical ingredients (APIs). With a strong presence in both domestic and international markets, J.B. Pharma focuses on therapeutic areas such as cardiology, gastroenterology, and anti-infectives. The company is renowned for its commitment to quality and innovation, which has positioned it as a trusted name in the industry. Notable achievements include a robust portfolio of over 100 products and a growing footprint in various global markets, underscoring its reputation as a reliable partner in healthcare solutions.
DitchCarbon Score
How does Jb Chemicals And Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Jb Chemicals And Pharma's score of 40 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Jb Chemicals And Pharma's reported carbon emissions
In 2024, J.B. Chemicals and Pharmaceuticals reported total carbon emissions of approximately 213,000,000 kg CO2e, comprising 8,608,580 kg CO2e from Scope 1, 37,544,060 kg CO2e from Scope 2, and a significant 188,603,000 kg CO2e from Scope 3 emissions. The Scope 3 emissions breakdown includes 106,010,000 kg CO2e from purchased goods and services, 28,699,000 kg CO2e from fuel and energy-related activities, and 22,480,000 kg CO2e from downstream transportation and distribution. In 2023, the company reported total emissions of about 137,000,000 kg CO2e, with Scope 1 emissions at 10,096,640 kg CO2e and Scope 2 emissions at 45,281,950 kg CO2e. The data indicates a trend of increasing emissions over the years, with 2022 figures showing approximately 76,380,000 kg CO2e for Scope 1 and 45,030,000 kg CO2e for Scope 2. J.B. Chemicals and Pharmaceuticals has set ambitious climate commitments, aiming to achieve carbon neutrality in its direct operations (Scope 1 and 2 emissions) by the fiscal year 2032-33. This long-term target reflects the company's commitment to reducing its carbon footprint and aligns with industry standards for sustainability. The emissions data is not cascaded from any parent organization, indicating that J.B. Chemicals and Pharmaceuticals independently reports its emissions and climate initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 7,638,000 | 00,000,000 | 0,000,000 |
| Scope 2 | 45,030,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | 000,000,000 | 000,000,000 |
How Carbon Intensive is Jb Chemicals And Pharma's Industry?
How Carbon Intensive is Jb Chemicals And Pharma's Location?
Jb Chemicals And Pharma's Scope 3 Categories Breakdown
Jb Chemicals And Pharma's Scope 3 emissions, which increased by 38% last year and increased by approximately 38% since 2023, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 56% of Scope 3 emissions.
Top Scope 3 Categories
Jb Chemicals And Pharma's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Jb Chemicals And Pharma has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
